Genstler D E, Keates R H
J Am Intraocul Implant Soc. 1983 Summer;9(3):317-20. doi: 10.1016/s0146-2776(83)80064-0.
Amvisc, a purified fraction of sodium hyaluronate, was evaluated and compared with Healon in cataract extraction and primary intraocular lens implantation. Both visco-elastic solutions are valuable adjuncts to intraocular surgery. A number of patients had moderately elevated IOP after these solutions had been used in the anterior chamber. This moderate elevation was observed less frequently with Amvisc than with Healon, and may be attributed to the lower viscosity of Amvisc. Both visco-elastic solutions provide good endothelial protection as evidenced by the minimal corneal edema seen in both groups. Postoperative anterior chamber inflammation was minimal in all patients in this study.
安维丝(Amvisc)是透明质酸钠的纯化组分,在白内障摘除和一期人工晶状体植入术中进行了评估并与喜辽妥(Healon)作比较。两种粘弹剂都是眼内手术的重要辅助材料。在这些溶液用于前房后,一些患者出现了中度眼压升高。安维丝组这种中度眼压升高的发生率低于喜辽妥组,这可能归因于安维丝的较低粘度。两组均可见最小程度的角膜水肿,证明两种粘弹剂均提供良好的内皮保护。本研究中所有患者术后前房炎症均很轻微。